マイページログイン
English
千葉大学学術成果リポジトリ
ブラウズ
著者
刊行年(西暦)
雑誌名
資料種別
ランキング
アクセスランキング
ダウンロードランキング
その他
アカデミック・リンク・センター/附属図書館HP
千葉大学HP
このアイテムのアクセス数:
137
件
(
2025-09-08
05:03 集計
)
閲覧可能ファイル
ファイル
フォーマット
サイズ
ダウンロード回数
説明
S03035476-99E-2-P17
pdf
687 KB
340
基本情報
データ種別:学術成果リポジトリ
タイトル
[Chiba Medical Society Young Investigator Award Minireview] Catalytic and non-catalytic functions of histone methyltransferase SETD1A in diseases
作成者
KIKUCHI, Sota
KANEDA, Atsushi
作成者ID
1000010313024
研究者リゾルバ
HOSHII, Takayuki
作成者ID
1000020464042
研究者リゾルバ
作成者の別表記
菊地, 創太
金田, 篤志
1000010313024
研究者リゾルバ
星居, 孝之
1000020464042
研究者リゾルバ
内容
[ABSTRACT]Histone modification plays an indispensable role in the regulation of transcription. The SET1/MLL family proteins are histone methyltransferases that are conserved from yeast to humans. SETD1A is one of six human SET1/MLL family proteins that primarily catalyzes H3K4 tri-methylation in vitro. SETD1A interacts with multiple subunits to form a complex, the generation of which enhances enzymatic activity and contributes to SETD1A-specific functions. As H3K4 tri-methylation serves as an active transcription marker, the SETD1A complex is believed to promote the transcription of downstream targets. Over the past decade, considerable work has been conducted on the involvement of SETD1A in human diseases. SETD1A is upregulated in cancers and its elevated expression is correlated with poor prognosis, whereas loss-of-function mutations in SETD1A are associated with neurodevelopmental disorders, such as schizophrenia. A SETD1A knockout mouse model has been characterized by abnormal neurotransmission and neural circuit formation and exhibits schizophrenia-like symptoms. Consequently, SETD1A is assumed to play essential roles in cell proliferation, differentiation, and metabolism. Recently, our group and others have identified the non-catalytic functions of SETD1A, as well as the non-canonical substrates of SETD1A. Importantly, many studies have revealed that SETD1A regulates the DNA damage repair pathway via both canonical and non-canonical routes. However, the underlying molecular mechanisms remain unclear and require further investigation. Here, we review the catalytic and non-catalytic functions of SETD1A in different diseases.
ハンドルURL
https://opac.ll.chiba-u.jp/da/curator/900121675/
フルテキストへのリンク
https://opac.ll.chiba-u.jp/da/curator/900121675/S03035476-99E-2-P17.pdf
公開者
The Chiba Medical Society
公開者の別表記
千葉医学会
NII資源タイプ
学術雑誌論文
ISSN
03035476
24334235
NCID
AN00142148
掲載誌名
Chiba medical journal
巻
99E
号
2
開始ページ
17
終了ページ
25
刊行年月
2023-04-10
selfDOI
10.20776/S03035476-99E-2-P17
著者版フラグ
publisher
カテゴリ
Chiba Medical Journal (ONLINE ISSN 2433-4235)
その他の情報を表示
DCMI資源タイプ
text
ファイル形式 [IMT]
application/pdf
言語 [ISO639-2]
eng
トップページへ戻る